Argent Biopharma Ltd (RGT.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2010 | 06-2009 | 06-2008 | 06-2007 | |
| Cash Flows From Operating Activities | ||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -6 | -124 | -80 | -222 |
| Net Acquisitions | N/A | N/A | N/A | -394 |
| Purchase Sale Intangibles | -9 | N/A | N/A | N/A |
| Other Investing Activity | 451 | -10,209 | 42 | 56 |
| Investing Cash Flow | $436 | $-10,334 | $-38 | $-560 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 900 | 11,685 | 454 | 736 |
| Debt Repayment | -1,604 | -386 | -266 | -541 |
| Common Stock Issued | 51 | N/A | N/A | 3,569 |
| Other Financing Activity | 430 | 0 | 0 | -1,502 |
| Financing Cash Flow | $-224 | $11,299 | $188 | $2,261 |
| Beginning Cash Position | 890 | 636 | 1,143 | 118 |
| End Cash Position | 59 | 890 | 636 | 1,143 |
| Net Cash Flow | $-830 | $253 | $-506 | $1,025 |
| Free Cash Flow | ||||
| Capital Expenditure | -15 | -144 | -42 | -56 |
| Free Cash Flow | -15 | -144 | -42 | -56 |